ArticleInternational journal of molecular sciences2024

Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy.

Mai Yamazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.